Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Gregory

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Short-term therapy for acute myelogenous leukemiaA Z Rohatiner, W M Gregory, R Bassan, et al.
Hematological Oncology|January 1, 1990
Acute myeloid leukemia in elderly adultsJ Tucker, A E Thomas, W M Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cyclophosphamide in small-cell carcinoma of the lungR L Souhami, G Finn, W M Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancerD W Miles, O Fogarty, C M Ash, et al.
British Journal of Haematology|November 1, 1986
Treatment of acute lymphoblastic leukaemia in adultsM J Barnett, M F Greaves, J A Amess, et al.
British Journal of Cancer|May 18, 2001
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trialB W Hancock, W M Gregory, M H Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Meta-analysis to evaluate the role of interferon in follicular lymphomaA Z S Rohatiner, W M Gregory, B Peterson, et al.
Pilot and Feasibility Studies|December 15, 2016
The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Pilot and Feasibility Studies|December 16, 2016
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphomaD C Linch, P Smith, B W Hancock, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Short-term therapy for acute myelogenous leukemiaA Z Rohatiner, W M Gregory, R Bassan, et al.
Hematological Oncology|January 1, 1990
Acute myeloid leukemia in elderly adultsJ Tucker, A E Thomas, W M Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cyclophosphamide in small-cell carcinoma of the lungR L Souhami, G Finn, W M Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancerD W Miles, O Fogarty, C M Ash, et al.
British Journal of Haematology|November 1, 1986
Treatment of acute lymphoblastic leukaemia in adultsM J Barnett, M F Greaves, J A Amess, et al.
British Journal of Cancer|May 18, 2001
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trialB W Hancock, W M Gregory, M H Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Meta-analysis to evaluate the role of interferon in follicular lymphomaA Z S Rohatiner, W M Gregory, B Peterson, et al.
Pilot and Feasibility Studies|December 15, 2016
The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Pilot and Feasibility Studies|December 16, 2016
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphomaD C Linch, P Smith, B W Hancock, et al.
Pageof 9